Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Boggio

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Reviews in Clinical and Experimental Hematology|February 15, 2002
Acquired hemophiliaL N Boggio, D Green
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Exercise may decrease further destruction in the adult haemophilic jointS Harris, L N Boggio
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Factor VIII inhibitor associated with peginterferon--a follow upC H Herman, L N Boggio, D Green
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Clinical and laboratory phenotype variability in type 2M von Willebrand diseaseA L Doruelo, S L Haberichter, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 5, 2017
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleedingM Wang, J B Lawrence, D V Quon, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Reviews in Clinical and Experimental Hematology|February 15, 2002
Acquired hemophiliaL N Boggio, D Green
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Exercise may decrease further destruction in the adult haemophilic jointS Harris, L N Boggio
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Factor VIII inhibitor associated with peginterferon--a follow upC H Herman, L N Boggio, D Green
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Clinical and laboratory phenotype variability in type 2M von Willebrand diseaseA L Doruelo, S L Haberichter, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 5, 2017
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleedingM Wang, J B Lawrence, D V Quon, et al.
Pageof 1